Accord Drug Patent Portfolio
Accord owns 1 orange book drug protected by 5 US patents Given below is the list of Accord's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11717555 | Pharmaceutical compositions having a selected release duration | 01 Jan, 2039 | Active |
| US12133878 | Pharmaceutical compositions having a selected release duration | 18 Dec, 2037 | Active |
| US10646572 | Pharmaceutical compositions with enhanced stability | 16 Jan, 2027 | Active |
| US9572857 | Pharmaceutical compositions with enhanced stability | 16 Jan, 2027 | Active |
| US9744207 | Pharmaceutical compositions with enhanced stability | 16 Jan, 2027 | Active |
Latest Legal Activities on Accord's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Accord.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| transaction for FDA Determination of Regulatory Review Period | 29 Feb, 2024 | US9572857 |
| transaction for FDA Determination of Regulatory Review Period | 29 Feb, 2024 | US10646572 |
| transaction for FDA Determination of Regulatory Review Period | 29 Feb, 2024 | US9744207 |
| transaction for FDA Determination of Regulatory Review Period | 07 Feb, 2024 | US9744207 |
| transaction for FDA Determination of Regulatory Review Period | 07 Feb, 2024 | US9572857 |
| transaction for FDA Determination of Regulatory Review Period | 07 Feb, 2024 | US10646572 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 20 Oct, 2023 | US10646572 |
| Entity Status Set To Undiscounted (Initial Default Setting or Status Change) | 19 Oct, 2023 | US10646572 |
|
Email Notification
Critical
| 08 Aug, 2023 | US11717555 |
| Patent eGrant Notification | 08 Aug, 2023 | US11717555 |
|
Recordation of Patent Grant Mailed
Critical
| 08 Aug, 2023 | US11717555 |
| Mail Patent eGrant Notification | 08 Aug, 2023 | US11717555 |
|
Electronic Review
Critical
| 08 Aug, 2023 | US11717555 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 08 Aug, 2023 | US11717555 |
| Recordation of Patent eGrant | 08 Aug, 2023 | US11717555 |
Accord's Family Patents
Accord Drug List
Given below is the complete list of Accord's drugs and the patents protecting them.
1. Camcevi Kit
Camcevi Kit is protected by 5 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11717555 | Pharmaceutical compositions having a selected release duration |
01 Jan, 2039
(13 years from now)
| Active |
| US12133878 | Pharmaceutical compositions having a selected release duration |
18 Dec, 2037
(12 years from now)
| Active |
| US10646572 | Pharmaceutical compositions with enhanced stability |
16 Jan, 2027
(1 year, 2 months from now)
| Active |
| US9572857 | Pharmaceutical compositions with enhanced stability |
16 Jan, 2027
(1 year, 2 months from now)
| Active |
| US9744207 | Pharmaceutical compositions with enhanced stability |
16 Jan, 2027
(1 year, 2 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Camcevi Kit's drug page